Why did Egypt choose the Chinese vaccine to fight the Crown? … Answers «Health»

Dr. Noha Assem, Advisor to the Minister of Health for Research Affairs and a member of the Scientific Committee to Combat the Crown, revealed the reason why Egypt chose the Chinese vaccine to deal with the virus.

Speaking to the program this morning, on the Extra News screen, on the CBC screen, he said that based on the instructions of Dr. Hala Zayed, Minister of Health, the vaccine is distributed to the most vulnerable groups, explaining that the Chinese vaccine was chosen on a scientific basis through research. The medical history, the history of these vaccines, the types of vaccines, and the technologies on which the vaccine was built, which are similar to other virus vaccines.

He added that based on the available information, priorities have been established for the technology in which the vaccine was manufactured, explaining that the Chinese vaccine is similar to other types of vaccines, which are distributed in Egypt, such as the vaccine against polio and others. regular vaccinations, and he said: “We are used to this type. Since vaccination, it is quick, easy and classic, we have vaccines that are similar to the vaccine with the same technology, successful, effective and safe, and Asim confirmed that the Oxford vaccine is among the other vaccines that the Egyptian Ministry of Health gives priority, along with the Chinese vaccine.

And he continued that the planning and monitoring phase of the development of Corona vaccines in the world began months ago, from the monitoring of vaccines and their scope to the third phase of clinical trials, so the results could be promising to think about give the vaccine.

The adviser to the Minister of Health went on to say that Egypt was eager to participate in clinical trials of the vaccine, including the Chinese vaccine, and explained that there was an arrangement in priorities, which is one of the most important protocols in the world to initiate vaccination. because it is difficult to provide the vaccine, in the early stages of the entire world population. .